NEUROCRINE BIOSCIENCES INC
NBIX
59 insider filings · Latest: Aug 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Feb 13 9:34 PM | DARIN LIPPOLDT | Proposed Sale | 1,098 | $117.18 | $128.7K | — | View → |
| Feb 13, 2025 | Feb 13 9:34 PM | ERIC BENEVICH | Proposed Sale | 1,098 | $117.18 | $128.7K | — | View → |
| Feb 13, 2025 | Feb 13 9:34 PM | JUDE ONYIA | Proposed Sale | 1,432 | $117.18 | $167.8K | — | View → |
| Feb 13, 2025 | Feb 13 9:33 PM | INGRID DELAET | Proposed Sale | 716 | $117.18 | $83.9K | — | View → |
| Feb 13, 2025 | Feb 13 9:33 PM | DAVID WARREN BOYER | Proposed Sale | 955 | $117.18 | $111.9K | — | View → |
| Feb 13, 2025 | Feb 13 9:33 PM | JULIE COOKE | Proposed Sale | 796 | $117.18 | $93.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:32 PM | KYLE GANO | Proposed Sale | 1,352 | $117.18 | $158.4K | — | View → |
| Feb 13, 2025 | Feb 13 9:31 PM | Kevin Charles Gorman | Proposed Sale | 2,832 | $117.18 | $331.9K | — | View → |
| Feb 10, 2025 | Feb 10 9:33 PM | KYLE W GANO | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
| Feb 10, 2025 | Feb 10 9:33 PM | JULIE SMITH COOKE | Proposed Sale | 700 | $122.62 | $85.8K | — | View → |
| Feb 10, 2025 | Feb 10 9:33 PM | DAVID WARREN BOYER | Proposed Sale | 700 | $122.62 | $85.8K | — | View → |
| Feb 10, 2025 | Feb 10 9:32 PM | ERIC BENEVICH | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
| Feb 10, 2025 | Feb 10 9:32 PM | KEVIN CHARLES GORMAN | Proposed Sale | 2,274 | $122.62 | $278.8K | — | View → |
| Feb 10, 2025 | Feb 10 9:32 PM | DARIN LIPPOLDT | Proposed Sale | 911 | $122.62 | $111.7K | — | View → |
| Feb 10, 2025 | Feb 10 9:31 PM | EIRY WYN ROBERTS | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
| Feb 10, 2025 | Feb 10 9:30 PM | MATTHEW C ABERNETHY | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
| Feb 3, 2025 | Feb 3 9:19 PM | INGRID DELAET | Proposed Sale | 623 | $151.82 | $94.6K | — | View → |
| Jan 31, 2025 | Jan 31 9:34 PM | JULIE COOKE | Proposed Sale | 824 | $153.29 | $126.3K | — | View → |
| Jan 31, 2025 | Jan 31 9:33 PM | KEVIN CHARLES GORMAN | Proposed Sale | 2,707 | $153.29 | $415.0K | — | View → |
| Jan 31, 2025 | Jan 31 9:32 PM | EIRY WYN ROBERTS | Proposed Sale | 1,457 | $153.29 | $223.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 17 10:48 PM | David W. BoyerChief Corp. Affairs Officer | Option Exercise | 1,600 | — | 4,801(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Grant/Award | 134,972 | $124.12 | 20,142(D) | View → |
| Feb 13, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 4,807 | — | 2,566(D) | View → |
| Feb 12, 2026 | Feb 17 10:48 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 4,907 | — | 14,721(D) | View → |
| Feb 13, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Grant/Award | 64,788 | $124.12 | 9,669(D) | View → |
| Feb 13, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 5,407 | — | 2,717(D) | View → |
| Feb 12, 2026 | Feb 17 10:47 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 2,560 | — | 7,681(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Grant/Award | 42,652 | $124.12 | 6,365(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Option Exercise | 4,044 | — | 2,083(D) | View → |
| Feb 12, 2026 | Feb 17 10:46 PM | Eric BenevichChief Commercial Officer | Option Exercise | 2,005 | — | 6,017(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Option Exercise | 2,911 | — | 1,510(D) | View → |
| Feb 13, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Grant/Award | 31,854 | $124.12 | 4,754(D) | View → |
| Feb 12, 2026 | Feb 17 10:46 PM | Julie CookeChief Human Resources Officer | Option Exercise | 1,387 | — | 4,161(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Option Exercise | 4,100 | — | 2,083(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Grant/Award | 41,033 | $124.12 | 6,124(D) | View → |
| Feb 12, 2026 | Feb 17 10:45 PM | Darin LippoldtChief Legal Officer | Option Exercise | 1,792 | — | 5,377(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Grant/Award | 36,713 | $124.12 | 5,479(D) | View → |
| Feb 13, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 2,760 | — | 1,359(D) | View → |
| Feb 12, 2026 | Feb 17 10:45 PM | Ingrid DelaetChief Regulatory Officer | Option Exercise | 1,600 | — | 4,801(D) | View → |
| Feb 13, 2026 | Feb 17 10:44 PM | Kevin Charles GormanDirector | Option Exercise | 10,981 | — | 5,377(D) | View → |